Clinical Trials Directory

Trials / Conditions / Epidermal Growth Factor Receptor

Epidermal Growth Factor Receptor

7 registered clinical trials studyying Epidermal Growth Factor Receptor — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
NCT07462377
EpiBiologicsPhase 1
RecruitingBolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary
NCT07073365
Pusan National University HospitalPhase 2
RecruitingIntrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
NCT05805631
Taipei Veterans General Hospital, TaiwanPhase 2
RecruitingBiologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Meas
NCT06059690
Jonsson Comprehensive Cancer CenterPhase 1 / Phase 2
UnknownCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma
NCT04664244
Lei LiPhase 2
UnknownTargeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC
NCT03074864
Guangdong Provincial People's HospitalPhase 2 / Phase 3
TerminatedRapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
NCT02770014
Dana-Farber Cancer InstitutePhase 2